
Please try another search
On Tuesday, JMP Securities maintained a positive stance on Cidara Therapeutics (NASDAQ:CDTX), reaffirming a Market Outperform rating and a $47.00 price target, well above the current trading price of...
SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC)...
On Friday, JMP Securities adjusted their financial outlook for Cidara Therapeutics (NASDAQ:CDTX), increasing the price target to $47.00, up from the previous $46.00, while reaffirming a Market...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review